Insider Transactions
Showing insider trading activity for Gerberding Julie L..
Insider Trading Activity Chart
Visualizing insider transactions on stock price candles
Transaction Type
Insider Role
Min Transaction Value
No stock price data available.
Recent Filings
| Symbol | Name | Filed | Transaction | Type | Role | Shares |
|---|---|---|---|---|---|---|
| HLVX | Gerberding Julie L. | 17 Sept 2025 | 17 Sept 2025 | U-Tender | director | 59,224 |
| MCK | Gerberding Julie L. | 31 Jul 2025 | 30 Jul 2025 | A-Award | director | 301 |
| HLVX | Gerberding Julie L. | 25 Jun 2025 | 23 Jun 2025 | A-Award | director | 17,199 |
| HLVX | Gerberding Julie L. | 30 Apr 2025 | 6 Jun 2024 | A-Award | director | 22,500 |
| MCK | Gerberding Julie L. | 10 Feb 2025 | 7 Feb 2025 | A-Award | director | 176 |
| MCK | Gerberding Julie L. | 10 Feb 2025 | 3 Feb 2025 | director: | 0 | |
| HLVX | Gerberding Julie L. | 9 Jun 2023 | 7 Jun 2023 | A-Award | director | 22,500 |
| HLVX | Gerberding Julie L. | 23 Aug 2022 | 19 Aug 2022 | A-Award | director: | 25,000 |
| HLVX | Gerberding Julie L. | 23 Aug 2022 | 19 Aug 2022 | A-Award | director | 25,000 |
| CERN | Gerberding Julie L. | 9 Jun 2022 | 7 Jun 2022 | U-Tender | director | 15,032 |
| HLVX | Gerberding Julie L. | 28 Apr 2022 | 28 Apr 2022 | director | 0 | |
| MRK | Gerberding Julie L. | 28 Feb 2022 | 24 Feb 2022 | A-Award | EVP, Chief Patient Officer | 9,550 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 11,414 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 19,394 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 30,175 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 35,287 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | S-Sale | EVP, Chief Patient Officer | 96,270 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 11,414 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 19,394 |
| MRK | Gerberding Julie L. | 3 Nov 2021 | 1 Nov 2021 | M-Exempt | EVP, Chief Patient Officer | 35,287 |